|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Nov. 12 | Wcg Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes | CI |
| 25-09-15 | WCG Announces the Launch of WCG ClinSphere E eReview Manager | CI |
Business description: WCG Clinical, Inc.

Executive Committee: WCG Clinical, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Srivastava Sam
CEO | Chief Executive Officer | - | 2022-05-17 |
Robert VanHees
PSD | President | - | - |
Ian Neilson
CTO | Chief Tech/Sci/R&D Officer | - | 2017-12-31 |
Lindsay McNair
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Forster
CMP | Compliance Officer | - | - |
Composition of the Board of Directors: WCG Clinical, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
John Baumer
BRD | Director/Board Member | 58 | 2018-12-31 |
Eugene Gorbach
BRD | Director/Board Member | 49 | 2011-12-31 |
| Director/Board Member | 50 | 2019-12-31 | |
Stephen McLean
BRD | Director/Board Member | 68 | 2011-12-31 |
Kavita Patel
BRD | Director/Board Member | 52 | 2020-10-31 |
Richard Pilnik
BRD | Director/Board Member | 69 | 2021-03-31 |
James Rothman
BRD | Director/Board Member | 76 | 2012-01-31 |
Peter Zippelius
BRD | Director/Board Member | 47 | 2018-12-31 |
| Director/Board Member | - | 2011-12-31 | |
| Director/Board Member | - | - |
Company details: WCG Clinical, Inc.

Other Biotechnology & Medical Research
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 6.07B | ||
| +1.74% | +0.55% | -1.64% | -9.59% | 45.62B | ||
| -1.20% | -0.36% | +34.42% | +22.90% | 34.34B | ||
| -0.89% | +2.25% | +28.92% | +27.68% | 29.46B | ||
| -0.97% | -3.42% | +14.97% | -16.20% | 28.09B | ||
| +0.22% | -2.71% | +169.96% | +361.83% | 19.11B | ||
| -1.01% | +4.38% | +58.47% | +198.43% | 14.78B | ||
| +2.31% | -6.43% | +2,918.75% | +3,811.51% | 14.25B | ||
| -1.59% | -0.97% | +65.77% | +157.65% | 14.09B | ||
| +0.25% | -4.10% | +35.07% | +2.59% | 13.25B | ||
| Average | -0.11% | -1.11% | +369.41% | +506.31% | 21.91B | |
| Weighted average by Cap. | -0.06% | -0.78% | +232.30% | +315.17% |
- Stock Market
- Equities
- WCGC Stock
- Company WCG Clinical, Inc.
Select your edition
All financial news and data tailored to specific country editions

















